Annals of surgery, 275(5), 972-978. Lippincott Williams and Wilkins Annals of Surgery. Lippincott Williams and Wilkins Annals of Surgery, 275(5), 972-978. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 40(11), 1220-1230. American Society of Clinical Oncology Versteijne, E, van Dam, J L, Suker, M, Janssen, Q P, Groothuis, K, Akkermans-Vogelaar, J M, Besselink, M G, Bonsing, B A, Buijsen, J, Busch, O R, Creemers, G-J M, van Dam, R M, Eskens, F A L M, Festen, S, de Groot, J W B, Groot Koerkamp, B, de Hingh, I H, Homs, M Y V, van Hooft, J E, Kerver, E D, Luelmo, S A C, Neelis, K J, Nuyttens, J, Paardekooper, G M R M, Patijn, G A, van der Sangen, M J C, de Vos-Geelen, J, Wilmink, J W, Zwinderman, A H, Punt, C J, van Tienhoven, G & van Eijck, C H J 2022, ' Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer : Long-Term Results of the Dutch Randomized PREOPANC Trial ', Journal of Clinical Oncology, vol. 40, no. 11, pp. 1220-1230 . https://doi.org/10.1200/JCO.21.02233 Journal of Clinical Oncology, 40(11), 1220-+. LIPPINCOTT WILLIAMS & WILKINS Journal of clinical oncology, 40(11), 1220-1230. American Society of Clinical Oncology
Annals of Surgery, 275(5), 979-984. LIPPINCOTT WILLIAMS & WILKINS Annals of Surgery, 275(5), 979-984. Lippincott Williams & Wilkins Dutch Pancreatic Cancer Group 2020, ' Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial) ', Annals of Surgery . https://doi.org/10.1097/SLA.0000000000004313 Annals of surgery, 275(5), 979-984. Lippincott Williams and Wilkins Annals of Surgery. Lippincott Williams and Wilkins
Journal of Clinical Oncology, 38(16), 1763-1773. AMER SOC CLINICAL ONCOLOGY Journal of clinical oncology, 38(16), 1763-1773. American Society of Clinical Oncology Journal of Clinical Oncology, 38(16), 1763-1773. American Society of Clinical Oncology J Clin Oncol
European Journal of Surgical Oncology, 47(10), 2525-2532. W.B. Saunders Ltd European Journal of Surgical Oncology, 47, 10, pp. 2525-2532 Dutch Pancreatic Cancer Group 2021, ' Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy : A multicentre retrospective cohort study ', European Journal of Surgical Oncology, vol. 47, no. 10, pp. 2525-2532 . https://doi.org/10.1016/j.ejso.2021.03.228 European journal of surgical oncology, 47(10), 2525-2532. W.B. Saunders Ltd European Journal of Surgical Oncology, 47, 2525-2532 EJSO-European Journal of Surgical Oncology, 47(10), 2525-2532. ELSEVIER SCI LTD European Journal of Surgical Oncology, 47(10), 2525-2532. W.B. Saunders
BMC Cancer BMC Cancer, 21(1):300. BioMed Central BMC cancer, 21(1):300. BioMed Central BMC Cancer, 21(1):300. BioMed Central Ltd BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021) Dutch Pancreatic Cancer Group 2021, ' Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial) : study protocol for a nationwide multicenter randomized controlled trial ', BMC Cancer, vol. 21, no. 1, 300 . https://doi.org/10.1186/s12885-021-08031-z BMC Cancer, 21(1). BMC BMC Cancer, 21(1):300. BioMed Central Ltd.
Acta Oncologica, 57(2), 195-202. Routledge/Taylor & Francis Group Acta Oncologica, 57(2), 195-202. Informa Healthcare Acta Oncologica, 57, 2, pp. 195-202 Coebergh van den Braak, R R J, van Rijssen, L B, van Kleef, J J, Vink, G R, Berbee, M, van Berge Henegouwen, M I, Bloemendal, H J, Bruno, M J, Burgmans, M C, Busch, O R C, Coene, P P L O, Coupé, V M H, Dekker, J W T, van Eijck, C H J, Elferink, M A G, Erdkamp, F L G, van Grevenstein, W M U, de Groot, J W B, van Grieken, N C T, de Hingh, I H J T, Hulshof, M C C M, Ijzermans, J N M, Kwakkenbos, L, Lemmens, V E P P, Los, M, Meijer, G A, Molenaar, I Q, Nieuwenhuijzen, G A P, de Noo, M E, van de Poll-Franse, L V, Punt, C J A, Rietbroek, R C, Roeloffzen, W W H, Rozema, T, Ruurda, J P, van Sandick, J W, Schiphorst, A H W, Schipper, H, Siersema, P D, Slingerland, M, Sommeijer, D W, Spaander, M C W, Sprangers, M A G, Stockmann, H B A C, Strijker, M, van Tienhoven, G, Timmermans, L M, Tjin-a-Ton, M L R, van der Velden, A M T, Verhaar, M J, Verkooijen, H M, Vles, W J, de Vos-Geelen, J M P G M, Wilmink, J W, Zimmerman, D D E, van Oijen, M G H, Koopman, M, Besselink, M G H & van Laarhoven, H W M 2018, ' Nationwide comprehensive gastro-intestinal cancer cohorts : the 3P initiative ', Acta Oncologica, vol. 57, no. 2, pp. 195-202 . https://doi.org/10.1080/0284186X.2017.1346381 Acta oncologica (Stockholm, Sweden), 57(2), 195-202. Informa Healthcare Acta Oncologica, 57(2), 195. Informa Healthcare Acta Oncologica, 57(2), 195-202 Acta Oncologica, 57, 195-202 Acta Oncologica, 57(2), 195-202. TAYLOR & FRANCIS LTD
European Journal of Cancer, 125, 83-93. Elsevier Ltd. European journal of cancer (Oxford, England, 125, 83-93. Elsevier Limited European Journal of Cancer, 125, 83. Elsevier Limited European Journal of Cancer, 125, 83-93. ELSEVIER SCI LTD